Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching.

Source:http://linkedlifedata.com/resource/pubmed/id/19064702

J. Exp. Med. 2008 Dec 22 205 13 3079-90

Download in:

View as

General Info

PMID
19064702